A study to compare a pediatric tablet or suspension of elvitegravir verses the adult 150 mg tablet in healthy adult volunteers

Mise à jour : Il y a 4 ans
Référence : EUCTR2015-000725-37

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of this study is to evaluate the relative bioavailability of two age-appropriate pediatric formulations (tablet and suspension formulation) of EVG co-administered with ritonavir in healthy adult subjects


Critère d'inclusion

  • Human Immunodeficiency Virus (HIV-1) Infection

Liens